Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03593811 · ClinicalTrials.gov registry record · Early Phase 1

Noninvasive Markers of Functional Nausea in Children

A Early Phase 1 study of Nausea, sponsored by Vanderbilt University Medical Center.

Active
Registry status
Early Phase 1
Development phase
42
Enrollment target
1
Study location

NCT03593811 is a Early Phase 1 study of Nausea that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 42 participants, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03593811, a Early Phase 1 study of Nausea, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.

Conditions Studied

Nausea

Interventions

  • DIAGNOSTIC_TEST Questionnaires
  • DIAGNOSTIC_TEST 4 channel electrogastrogram (EGG)
  • DIAGNOSTIC_TEST 36 channel high resolution electrogastrogram (HR-EGG)
  • DIAGNOSTIC_TEST Magnetogastrogram (MGG)
  • DIAGNOSTIC_TEST Electrocardiogram (EKG)

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-08-03
Est. Completion 2026-08-31
Phase Early Phase 1

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03593811

The ClinicalTrials.gov registry entry for NCT03593811 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (83% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nausea appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.

NCT03593811 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03593811 about?

NCT03593811 is a clinical study titled "Noninvasive Markers of Functional Nausea in Children". The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.

What is the current status of trial NCT03593811?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2018-08-03. Estimated completion is 2026-08-31.

What conditions does trial NCT03593811 study?

This clinical trial studies the following conditions: Nausea.

What interventions are being tested in trial NCT03593811?

The interventions under investigation include: Questionnaires (DIAGNOSTIC_TEST), 4 channel electrogastrogram (EGG) (DIAGNOSTIC_TEST), 36 channel high resolution electrogastrogram (HR-EGG) (DIAGNOSTIC_TEST), Magnetogastrogram (MGG) (DIAGNOSTIC_TEST), Electrocardiogram (EKG) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03593811?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03593811 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nausea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nausea

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.